The chief executive of the German pharmaceutical company BioNTech said he is confident its coronavirus vaccine works against the new UK variant, but that further studies are needed to be certain. 'Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variants,' Uğur Şahin said. If the vaccine needs to be adjusted for the new variant, the company could do that in about six weeks, he added
Covid vaccine 'highly likely' to work on UK variant, BioNTech says